{"slideshow_credits": null, "snippet": "Generic drug makers need samples of branded drugs in order to test their products and get them approved. Increasingly, brand-name manufacturers are refusing to sell them these samples.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "multimedia", "byline": null, "web_url": "http://www.nytimes.com/interactive/2013/04/15/business/Contention-in-Making-Generic-Drugs.html", "lead_paragraph": "Generic drug makers need samples of branded drugs in order to test their products and get them approved. Increasingly, brand-name manufacturers are refusing to sell them these samples.", "headline": {"seo": "Contention in Making Generic Drugs", "main": "Contention in Making Generic Drugs"}, "_id": "516c8021cf28d02a61000a07", "word_count": "201", "multimedia": [], "pub_date": "2013-04-15T00:00:00Z", "source": "The New York Times", "news_desk": "Business Day", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Celgene Corporation", "name": "organizations", "is_major": "N", "rank": "3"}, {"value": "Acorda Therapeutics Inc", "name": "organizations", "is_major": "N", "rank": "4"}, {"value": "Actelion Pharmaceuticals Ltd", "name": "organizations", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "Interactive Feature"}